Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial

Mohamed G. Zeinhom,Mohamed Fouad Elsayed Khalil,Islam Fathallah Mohamed Kamel,Ahmed Mohamed Kohail,Sherihan Rezk Ahmed,Ahmed Elbassiouny,Ashfaq Shuaib,Omar M Al-Nozha

DOI: https://doi.org/10.1038/s41598-024-56067-5

IF: 4.6

2024-03-14

Scientific Reports

Abstract:Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third of treated patients. We evaluated the post-stroke unfavourable outcome predictors in alteplase-treated patients from Egypt and Saudi Arabia. We assessed the effect of different risk factors on AIS outcomes after alteplase in Egypt and Saudi Arabia. Our study included 592 AIS alteplase-treated patients. The relationship between risk factors, clinical presentation, and imaging features was evaluated to predict factors associated with poor outcomes. An mRS score of three or more was used to define poor outcomes. Poor outcome was seen in 136 patients (23%), and Patients with unfavourable effects had significantly higher admission hyperglycaemia, a higher percentage of diabetes mellitus, cardioembolic stroke, and a lower percentage of small vessel stroke. Patients with higher baseline NIHSS score (OR 1.39; 95% CI 1.12–1.71; P = 0.003), admission hyperglycaemia (OR 13.12; 95% CI 3.37–51.1; P < 0.001), and post-alteplase intracerebral haemorrhage (OR 7.41; 95% CI 1.69–32.43; P = 0.008) independently predicted unfavourable outcomes at three months. In AIS patients treated with alteplase, similar to reports from other regions, in patients from Egypt and Saudi Arabia also reveal that higher NIHSS, higher serum blood sugar, and post-alteplase intracerebral haemorrhage were the predictors of unfavourable outcomes three months after ischemic stroke.

multidisciplinary sciences

What problem does this paper attempt to address?

This paper aims to address the issue of predicting adverse outcomes in patients with acute ischemic stroke (AIS) after receiving alteplase treatment. The study evaluated various risk factors, clinical presentations, and imaging characteristics of Egyptian and Saudi Arabian patients through a multicenter randomized trial to assess the impact on the effectiveness of alteplase treatment. The main findings include higher baseline NIHSS scores, hyperglycemia at admission, and intracranial hemorrhage after alteplase treatment as independent predictors of poor outcomes at 3 months. These results help improve the prognosis assessment of ischemic stroke in the Middle East and enhance the quality of stroke services.